The Karma Cardiology team is experienced in managing cardiovascular trials in many conditions and using different therapeutic approaches.
 
 

Conditions:

  • Acute myocardial infarction
  • Acute coronary syndrome
  • Cardiovascular disease
  • Congestive heart failure
  • Acute decompensated heart failure
  • Coronary artery disease
  • Hypertension
  • Acute cardiogenic pulmonary edema
  • Heart failure
     

Therapeutic Approaches:

  • Cell therapies
  • Devices
  • Drugs including:
  • Diuretics
  • Thrombolytics

Some Recent Assignments and Achievements:

Phase I Pharmacokinetic study of thromboxane antagonist

Phase I First in man – with a new class of drug in heart failure

Phase II Acute myocardial infarction

Phase II Acute coronary syndromes

Phase II Acute coronary syndrome

Phase II Congestive heart failure (stem cell study)

Phase II Acute decompensated heart failure

Phase II Acute myocardial infarction

Phase II Acute coronary syndrome

Phase II Cardiovascular disease

Phase II Two studies with a surgical device in Heart failure (NYHA III-NYHA IV patients)

Phase III Coronary artery disease

Phase III Hypertension (renal function in elderly patients)

Phase III Hypertension (investigation of plasma lipids)

Phase III Hypertension (pulmonary hypertension)

Phase III Hypertension (left ventricular hypertrophy)

Phase III Acute cardiogenic pulmonary edema

Phase III Cardiac failure

Phase III Acute myocardial infarction

Phase III Coronary Artery Disease

Phase III Global study in hypertension

Phase III Global study in Heart Failure

Phase III Global study in Heart Failure with device – responsibility for 6 countries and 40% of the patients

Phase IV Cardiac failure (patient acceptability in general practice)

Phase IV Cardiac failure (comparison of 2 different diuretics)

 


 

 






×

Make an appointment and we’ll contact you.